Imad Ashkar

Imad Ashkar

Auto-generated profile, based on publicly available information

Imad Ashkar

Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Jbeil, LBN

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2026 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
MDMohammad Daher
Mohammad Daher
IAImad Ashkar
Imad Ashkar
TPTarishi Parmar
Tarishi Parmar
LKLiam Kane
Liam Kane
JSJames R. Satalich
James R. Satalich
JAJoseph A. Abboud
Joseph A. Abboud

23 December 2025 in Spine Deformity
Verified
Journal Article
Closed access
PDF file
IAImad Ashkar
Imad Ashkar
DRDouaa El Rayes
Douaa El Rayes
HHHilda Habib
Hilda Habib
RZRazan Z. Zantout
Razan Z. Zantout
EMEduardo Muscogliati
Eduardo Muscogliati
ENElie Najjar
Elie Najjar

9 June 2026 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Open access
AAAkin A. Adio
Akin A. Adio
JHJennifer X. Hong
Jennifer X. Hong
AAAhab Alnemri
Ahab Alnemri
IAImad Ashkar
Imad Ashkar
NSNobuhiko Sumiyoshi
Nobuhiko Sumiyoshi
ANAnthony Ndu
Anthony Ndu
Coronal plane deformities of the ankle, including varus and valgus malalignment, present technical challenges in total ankle arthroplasty (TAA) and may affect implant performance, although their impact on short-term outcomes remains uncertain. To determine whether preoperative ankle varus or valgus deformity is associated with increased 2-year mechanical or implant-related complications following primary TAA. Retrospective cohort study using a national clinical database. A retrospective analysis was conducted using the TriNetX Research Network, identifying patients who underwent primary TAA. Separate matched comparisons were performed for patients with preoperative ankle varus deformity versus no varus, and for valgus deformity versus no valgus. Two-year outcomes included mechanical complications, periprosthetic joint infection, implant-related pain, revision surgery, arthrodesis, and subsequent total knee arthroplasty (TKA). Relative risks (RR) with 95% confidence intervals were calculated. Among 870 patients with varus deformity and 856 with valgus deformity, varus alignment was not associated with significant differences in any 2-year outcomes. In contrast, ankle valgus deformity was associated with increased risks of mechanical complications (5.02% vs 1.52%, RR 3.3, p < 0.001), implant pain (8.88% vs 4.79%, RR 1.85, p < 0.001), revision (6.19% vs 3.04%, RR 2.04, p = 0.002), arthrodesis (3.97% vs 2.22%, RR 1.79, p = 0.036), and subsequent TKA (7.86% vs 4.10%, RR 1.92, p = 0.004). Preoperative ankle valgus deformity was strongly associated with higher 2-year risks of mechanical complications following TAA, whereas varus deformity was not. Recognition of valgus alignment is important when counseling patients and planning TAA. III.

16 December 2025 in Journal of Orthopaedics
Verified
Journal Article
Open access
AAAkin Adio
Akin Adio
MFMiguel Fiandeiro
Miguel Fiandeiro
Jehad Feras AlSamhoriJehad Feras AlSamhori
Jehad Feras AlSamhori
IAImad Ashkar
Imad Ashkar
PBPeter Boufadel
Peter Boufadel
JAJoseph A. Abboud
Joseph A. Abboud
Cystic fibrosis-related bone disease contributes substantially to fragility fractures and morbidity in patients with cystic fibrosis (CF). Cystic Fibrosis Transmembrane conductance Regulator (CFTR) modulators have been shown to improve pulmonary and nutritional outcomes, but their impact on skeletal health remains incompletely defined. We conducted a retrospective cohort study using the TriNetX Research Network, which aggregates deidentified electronic medical records from 168 health care organizations. Patients with CF who initiated CFTR modulators between 2012 and 2023 were compared with matched CF patients without modulator exposure. Sub-analyses examined outcomes in patients receiving elexacaftor/tezacaftor/ivacaftor (ETI) versus non-ETI modulators. A 1:1 propensity score matching algorithm balanced demographic and clinical covariates. The primary outcome was 2-year fracture risk. Relative risks (RR) with 95 % confidence intervals (CI) were calculated. After matching, 5639 patients receiving CFTR modulators were compared with controls. Modulator therapy was associated with significantly reduced risk of overall fracture (RR 0.48, p < .0001), with protective effects observed for hand or wrist, forearm, upper limb, femur, lower leg, and vertebral fractures. Both ETI and non-ETI modulators were associated with significantly lower fracture risk compared with no therapy. There were no significant differences in fracture outcomes between ETI and non-ETI users. In this large, population-based analysis, CFTR modulator therapy was associated with lower 2-year fracture risk. These findings extend the benefits of modulator therapy beyond pulmonary and nutritional domains, highlighting its potential role in skeletal protection.

20 January 2026 in Spine Deformity
Verified
Journal Article
Closed access
PDF file
HAHussein Akil
Hussein Akil
IAImad Ashkar
Imad Ashkar
EMEduardo Muscogliati
Eduardo Muscogliati
NBNeel Badhe
Neel Badhe
DRDouaa El Rayes
Douaa El Rayes
ENElie Najjar
Elie Najjar

17 October 2026 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
TPTarishi Parmar
Tarishi Parmar
IAImad Ashkar
Imad Ashkar
VDViraj Deshpande
Viraj Deshpande
NPNiashi Parmar
Niashi Parmar
MDMohammad Daher
Mohammad Daher
JAJoseph A. Abboud
Joseph A. Abboud